Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T C Fagan

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Clinical Pharmacology and Therapeutics|April 1, 1989
Nicardipine and hydrochlorothiazide in essential hypertensionT C Fagan, R Brown, H Schnaper, et al.
Hypertension (Dallas, Tex. : 1979)|November 1, 1983
Time course of development of the antihypertensive effect of propranololT C Fagan, T Walle, R Corns-Hurwitz, et al.
The American Journal of Cardiology|October 30, 1998
Effects of candesartan cilexetil in patients with systemic hypertension. Candesartan Cilexetil Study InvestigatorsM Reif, W B White, T C Fagan, et al.
European Journal of Clinical Pharmacology|January 1, 1988
Doxazosin in patients with hypertensionK A Conrad, T C Fagan, M J Mackie, et al.
The American Journal of Cardiology|November 1, 1987
Similar efficacy of nitrendipine in young and elderly hypertensive patientsJ Mehta, L M Lopez, P C Deedwania, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 1, 1991
Prospective study of the safety and financial benefit of ketoconazole as adjunctive therapy to cyclosporine after heart transplantationS M Butman, J C Wild, P E Nolan, et al.
The American Journal of Medicine|February 1, 1993
Application of ambulatory blood pressure monitoring in differentiating between antihypertensive agentsJ M Neutel, D H Smith, C V Ram, et al.
British Journal of Clinical Pharmacology|March 1, 1982
Antihypertensive effects of lofexidine in patients with essential hypertensionT C Fagan, S S Bloomfield, T D Cowart, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Clinical Pharmacology and Therapeutics|April 1, 1989
Nicardipine and hydrochlorothiazide in essential hypertensionT C Fagan, R Brown, H Schnaper, et al.
Hypertension (Dallas, Tex. : 1979)|November 1, 1983
Time course of development of the antihypertensive effect of propranololT C Fagan, T Walle, R Corns-Hurwitz, et al.
The American Journal of Cardiology|October 30, 1998
Effects of candesartan cilexetil in patients with systemic hypertension. Candesartan Cilexetil Study InvestigatorsM Reif, W B White, T C Fagan, et al.
European Journal of Clinical Pharmacology|January 1, 1988
Doxazosin in patients with hypertensionK A Conrad, T C Fagan, M J Mackie, et al.
The American Journal of Cardiology|November 1, 1987
Similar efficacy of nitrendipine in young and elderly hypertensive patientsJ Mehta, L M Lopez, P C Deedwania, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 1, 1991
Prospective study of the safety and financial benefit of ketoconazole as adjunctive therapy to cyclosporine after heart transplantationS M Butman, J C Wild, P E Nolan, et al.
The American Journal of Medicine|February 1, 1993
Application of ambulatory blood pressure monitoring in differentiating between antihypertensive agentsJ M Neutel, D H Smith, C V Ram, et al.
British Journal of Clinical Pharmacology|March 1, 1982
Antihypertensive effects of lofexidine in patients with essential hypertensionT C Fagan, S S Bloomfield, T D Cowart, et al.
Pageof 5